文献速递传染病防控与疫情报告免疫规划卫生政策与健康促进

印度霍乱疫情图谱与抗生素耐药性霍乱弧菌:现有数据评估及文献范围综述

Mapping cholera outbreaks and antibiotic resistant Vibrio cholerae in India: An assessment of existing data and a scoping review of the literature.
PubMed 文献 · Vaccine · 2019-12-26

本文利用综合疾病监测规划(IDSP)数据识别2009至2017年印度27个邦与联邦属地共559起霍乱疫情,并按近五年疫情频次定义疫情易发地区。范围综述共识别62起抗生素耐药(ABR)霍乱疫情,其中西孟加拉邦、马哈拉施特拉邦、奥里萨邦和德里合计占三分之二。综述提示印度霍乱弧菌ABR呈上升趋势。

要点

  • 2009至2017年印度IDSP报告559起霍乱疫情,涉及27个邦与联邦属地。
  • 范围综述识别62起ABR霍乱疫情,西孟加拉邦14起、马哈拉施特拉邦10起、奥里萨邦10起、德里7起。
  • 综述提示印度霍乱弧菌分离株ABR呈上升趋势。

核心结论

  • 本范围综述提示印度霍乱弧菌分离株的抗生素耐药呈上升趋势。
  • 作者提出探索抗生素管理在腹泻临床管理中的作用、将疫苗接种作为减少选择压力的感染预防干预以及部署高质量实时监测系统。
  • 作者认为必须在霍乱ABR形成严重规模之前加以应对。

研究设计与样本

  • 研究采用Arksey与O'Malley框架开展范围综述。
  • 利用综合疾病监测规划(IDSP)报告的数据识别2009至2017年印度霍乱疫情。
  • 将最近五年(2012-2016年)中至少三年报告疫情、或最近五年中至少两年在同一年发生两次及以上疫情的邦与联邦属地定义为疫情易发地区。
  • 对同行评议文献中关于霍乱ABR疫情的出版物进行范围综述。

主要发现

  • 2009至2017年共识别559起霍乱疫情,影响27个邦与联邦属地。
  • 范围综述识别62起ABR疫情,其中西孟加拉邦14起、马哈拉施特拉邦10起、奥里萨邦10起、德里7起,四个邦与联邦属地合计占三分之二。

临床怎么用

  • 作者提出探索抗生素管理在腹泻临床管理中的作用。
  • 作者提出将疫苗接种作为减少选择压力的感染预防干预。
  • 作者提出部署可报告准确实时数据的高质量监测系统,以支持适当及时的公共卫生应对。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Although fluid and electrolyte replenishment remains the mainstay of clinical management of cholera, antibiotics are an important component of the strategy for clinical management of moderate to severe cases of cholera. The emergence of antibiotic resistance (ABR) in Vibrio cholerae has led to difficulties in case management. The past decade has also seen the development of cheap and effective oral cholera vaccines (OCVs). In addition to the two-dose strategy for widespread immunization, OCVs have also been shown to be effective in containing outbreaks using a single-dose schedule. In this scoping review we map the states and union territories (SUTs) of India which are prone to cholera outbreaks followed by a scoping review of peer-reviewed publications about ABR outbreaks of cholera employing the Arksey and O'Malley framework. Using the data reported by the Integrated Disease Surveillance Program (IDSP), we identified 559 outbreaks of cholera between 2009 and 2017, affecting 27 SUTs. We defined SUTs which had reported outbreaks in at least three out of the last five years (2012-2016) or had experienced two or more outbreaks in the same year in at least two of the last five years to be outbreak-prone. The scoping review identified 62 ABR outbreaks, with four SUTs accounting for two-thirds of them: West Bengal (14), Maharashtra (10), Odisha (10) and Delhi (7). Overall, this scoping review suggests that there is an increasing trend of ABR in Vibrio cholerae isolated from outbreaks in India. This opens up avenues for exploring the role of antibiotic stewardship in the clinical management of diarrhea, the institution of vaccination as an infection prevention intervention to reduce selection pressure, and the deployment of high quality surveillance systems which report accurate, real-time data allowing appropriate and timely public health responses. It is crucial to counter the issue of ABR in cholera before it assumes a menacing magnitude.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Chatterjee P, Kanungo S, Bhattacharya SK, et al. Mapping cholera outbreaks and antibiotic resistant Vibrio cholerae in India: An assessment of existing data and a scoping review of the literature. Vaccine. 2019. PMID: 31883807. doi:10.1016/j.vaccine.2019.12.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。